Items where authors include "Henry, M."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Griffen, E.J., Boulet, P., Albrecht, R. et al. (365 more authors) (2024) Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements. Wellcome Open Research, 9. 374. ISSN 2398-502X

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Boby, M.L., Fearon, D. orcid.org/0000-0003-3529-7863, Ferla, M. et al. (209 more authors) (2023) Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, 382 (6671). eabo7201. ISSN 0036-8075

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Jansen, J. orcid.org/0000-0003-0513-6102, Reimer, K.C. orcid.org/0000-0002-7118-9133, Nagai, J.S. orcid.org/0000-0002-7655-7206 et al. (208 more authors) (2022) SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell, 29 (2). 217-231.e8. ISSN 1934-5909